5-alpha-dihydrotestosterone elevations associated with phentermine use.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2018, v. 9, n. 8, p. 255, doi. 10.1177/2042018818776158
- By:
- Publication type:
- Article
Works matching IS 20420188 AND DT 2018 AND VI 9 AND IP 8
Results: 6
1
2
Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Letter
3
Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2018, v. 9, n. 8, p. 259, doi. 10.1177/2042018818767220
- By:
- Publication type:
- Article
4
Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2018, v. 9, n. 8, p. 231, doi. 10.1177/2042018818781669
- By:
- Publication type:
- Article
5
Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2018, v. 9, n. 8, p. 241, doi. 10.1177/2042018818781414
- By:
- Publication type:
- Article
6
The clinical significance of hyperglycemia in nondiabetic critically ill multiple trauma patients.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2018, v. 9, n. 8, p. 223, doi. 10.1177/2042018818779746
- By:
- Publication type:
- Article